Tech Company Financing Transactions
Sun Genomics Funding Round
Sun Genomics secured a $8.7 million Series A funding round on 6/30/2020. Backers included Pangaea Ventures, Danone Manifesto Ventures and Human Longevity.
Transaction Overview
Company Name
Announced On
6/30/2020
Transaction Type
Venture Equity
Amount
$8,650,000
Round
Series A
Investors
Pangaea Ventures (Lead Investor) (Chris Erickson)
Proceeds Purpose
The company will use this funding to support its growth in the custom probiotics market, scale delivery across the U.S., enter international markets, and accelerate the publication of its studies in partnership with academic institutions.
Company Information
Company Status
Private & Independent
Industry
Consumer
Mailing Address
5151 Shoreham Pl. 105
San Diego, CA 92122
USA
San Diego, CA 92122
USA
Phone
Website
Email Address
Overview
Sun Genomics is the only custom probiotic with the secret ingredient. That secret ingredient is your gut microbiota. We create custom probiotics tailored and formulated to your unique DigestiveDNA to improve your digestion, increase your energy, and reduce bloating helping you perform at your best.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sunny Jain
Chief Operating Officer
Neal Gidvani
Chief Technical Officer
Thibaut Montagne
VP - Finance
Scott Moon
VP - Manufacturing
Zenas George
Browse more venture capital transactions:
Prev: 6/30/2020: Artlist venture capital transaction
Next: 6/30/2020: Enko Chem venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs